文献速递创伤与烧伤重症综合管理与镇静镇痛

培养下一代创伤外科医师-科学家:20年研究投资反思

Growing the next generation of trauma surgeon-scientists: Reflections on 20 years of research investment.
PubMed 文献 · J Trauma Acute Care Surg · 2022-06-01
一句话结论东部创伤外科协会20年研究奖学金与INVEST-C项目使受资助者获得显著院外资助,近5年INVEST-C参与者学术产出已与奖学金获得者相当。

本文回顾东部创伤外科协会(EAST)20年研究奖学金(2002-2021年,n=20)及INVEST-C Hack-a-thon项目(2017-2020年,n=19)对学术产出的影响。奖学金获得者中位论文56篇(IQR 33-88),h指数16(IQR 12-21),25%获得至少1项NIH资助;近10年奖学金获得者中40%获NIH资助,同期平均NIH资助率为18.5%。最近5年奖学金获得者与INVEST-C参与者的总论文数(33 vs 34,p=0.7)和h指数(p=0.1)无差异,但INVEST-C参与前无人持有研究资助,参与后31.6%(6/19)获得至少1项资助(11项非NIH,1项NIH)。作者认为研究活动投资已转化为显著的院外资助。

要点

  • 20年研究奖学金获得者中位论文56篇(IQR 33-88),h指数16(IQR 12-21),25%获至少1项NIH资助。
  • 近10年奖学金获得者中40%获NIH资助,同期平均NIH资助率为18.5%。
  • 在学术机构任职者中,距奖学金>5年者论文数66篇(IQR 51-115)高于<5年者33篇(IQR 22-59),p=0.05;h指数无差异(16 vs 15,p=NS)。
  • 最近5年奖学金获得者与INVEST-C参与者总论文数无差异(33 vs 34,p=0.7),h指数无差异(p=0.1)。
  • INVEST-C参与前无人持有研究资助,参与后31.6%(6/19)获得至少1项资助(11项非NIH,1项NIH)。

适用人群与场景

  • 2002-2021年EAST研究奖学金获得者(n=20)及2017-2020年INVEST-C参与者(n=19)。

研究设计与关键结果

  • 研究类型为对EAST研究奖学金(2002-2021年,n=20)和INVEST-C项目(2017-2020年,n=19)参与者的学术产出回顾性分析。
  • 奖学金获得者中位论文56篇(IQR 33-88),h指数16(IQR 12-21),25%获得至少1项NIH资助。
  • 近10年奖学金获得者中40%获NIH资助,同期平均NIH资助率为18.5%。
  • 在学术机构任职者(奖学金获得者90%)中,距奖学金>5年者论文数66篇(IQR 51-115)高于<5年者33篇(IQR 22-59),p=0.05;h指数无差异(16 [IQR 14-25] vs 15 [IQR 9-19],p=NS)。
  • 最近5年奖学金获得者与INVEST-C参与者总论文数无差异(33 [IQR 22-59] vs 34 [IQR 18-44],p=0.7),h指数无差异(INVEST-C 9 [IQR 5-14],p=0.1)。
  • INVEST-C参与前无人持有研究资助,参与后31.6%(6/19)获得至少1项资助(11项非NIH,1项NIH)。

证据类型、等级与局限

  • 证据类型为预后与流行病学研究,证据等级Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为研究活动投资已转化为显著的院外资助,近5年尤其富有成果,INVEST-C参与者已获得与奖学金获得者相当的中位学术产出。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The Eastern Association for the Surgery of Trauma mission includes fostering research and providing career development opportunities. Eastern Association for the Surgery of Trauma has awarded for 20 years a research scholarship to a promising young investigator. The research mentorship efforts were expanded 5 years ago with the INVEST-C Hack-a-thon. INVEST-C provides an intensive, short-term engagement to propel junior faculty toward establishing research independence. This study investigates the impact of these programs on academic productivity.

METHODS: Pubmed records, National Institutes of Health (NIH) Reporter data, and SCOPUS h-index were acquired for all scholarship (SCH) awardees from 2002 to 2021 (n = 20) and all INVEST-C (INV) participants (2017-2020, n = 19). Current type of practice, total number of funding awards, and timing of first award were ascertained. INVEST-C participants were also surveyed on an annual basis to track their progress. Medians (interquartile range [IQR]) are reported and compared (analysis of variance).

RESULTS: Median publications (PUBs) of SCH awardees were 56 (IQR, 33-88), h-index was 16 (IQR, 12-21), and 25% of awardees have ≥1 NIH grant since their SCH. Among the last 10 awardees with a minimum of 2 years from SCH, 40% have received an NIH award compared with a mean NIH funding rate of 18.5% over the same period. For those remaining in academics (90% SCH), PUBs were higher for those >5 years (66 [IQR, 51-115]) versus <5 years from their SCH (33 [22-59]; p = 0.05), but there was no difference in h-index (16 [IQR, 14-25] vs. 15 [9-19], p = NS). Comparing the most recent 5 years of SCH to INV group, there was no difference in academic productivity as measured by total PUBs (SCH, 33 [IQR, 22-59] vs. INV, 34 [IQR, 18-44]; p = 0.7) or h-index (INV, 9 [IQR, 5-14]; p = 0.1). However, no attendee held research funding before INV, but 31.6% (6 of 19 attendees) have subsequently acquired ≥1 funding award (11 non-NIH, 1 NIH) in the short interval since participation.

CONCLUSION: Investments in research activities have translated to significant extramural funding. Those in the last 5 years have been particularly fruitful with INV participants already achieving equal median academic productivity to SCH recipients.

LEVEL OF EVIDENCE: Prognostic and Epidemiologic; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Callcut RA, Dixon R, Smith JW, et al. Growing the next generation of trauma surgeon-scientists: Reflections on 20 years of research investment. J Trauma Acute Care Surg. 2022. PMID: 35653510. doi:10.1097/TA.0000000000003714

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。